TEVA Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

32.435

Open

32.270

VWAP

32.16

Vol

4.96M

Mkt Cap

37.28B

Low

32.010

Amount

159.60M

EV/EBITDA(TTM)

9.59

Total Shares

1.16B

50.03B

EV/OCF(TTM)

30.34

P/S(TTM)

2.11

Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.

Events Timeline

(ET)

2026-03-30

09:10:00

Teva Receives FDA Approval for Ponlimsi as Prolia Biosimilar

2026-03-30

09:10:00

Teva Submits Biosimilar Application for Xolair

2026-03-03 (ET)

2026-03-03

17:10:00

Teva and Blackstone Life Sciences Announce $400M Strategic Funding Agreement

2026-02-20 (ET)

2026-02-20

15:00:00

Teva's TEV-'749 New Drug Application Accepted by FDA

News

8.5

04-19Yahoo Finance

PinnedTeva Pharmaceutical Featured in Einhorn's Top Stock Picks

2.0

04-18NASDAQ.COM

Teva's FDA Approval of Long-Acting Drug Could Be Major Catalyst

8.5

04-18Fool

Teva Pharmaceutical Shares Surge 130% with Optimistic Outlook

2.0

04-14seekingalpha

Greenlight Capital Achieves 6.5% Return in Q1 Amid Market Decline

4.5

04-08NASDAQ.COM

ACWX ETF 52-Week Price Analysis

8.5

04-03NASDAQ.COM

Biotech Landscape Update: Regulatory Approvals and Acquisitions

11 Analyst Rating

Wall Street analysts forecast TEVA stock price to rise

10 Buy

1 Hold

0 Sell

Strong Buy

Current: 0.000

Low

29.00

Averages

35.71

High

40.00

Current: 0.000

Low

29.00

Averages

35.71

High

40.00

BofA

Buy

maintain

$38 -> $42

AI Analysis

2026-04-09

Reason

BofA

Price Target

$38 -> $42

AI Analysis

2026-04-09

maintain

Buy

Reason

BofA raised the firm's price target on Teva to $42 from $38 and keeps a Buy rating on the shares. The firm adjusted several targets in conjunction with its Q1 preview for its large-cap pharma and small-to-mid cap biopharma coverage.

Piper Sandler

David Amsellem

Overweight

maintain

$40 -> $41

2026-03-04

Reason

Piper Sandler

David Amsellem

Price Target

$40 -> $41

2026-03-04

maintain

Overweight

Reason

Piper Sandler analyst David Amsellem raised the firm's price target on Teva to $41 from $40 and keeps an Overweight rating on the shares after meeting with management. Key discussion topics included a number of bigger picture considerations, including management's approach to innovative R&D and its vision for the R&D organization; how the team is thinking about further build-out of its core neuroscience and immunology verticals; its vision for the biosimilars business; and the approach to capital deployment amid growth in cash generation. With an attractive long-term top-line/EBITDA growth story coming into focus, in the context of continued improvement in the capital structure and an absence of loss of exclusivity exposure, the firm would argue for further multiple expansion from a current EV/2026 EBITDA of 10 times.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for TEVA

Unlock Now

Valuation Metrics

The current forward P/E ratio for Teva Pharmaceutical Industries Ltd (TEVA.N) is 11.93, compared to its 5-year average forward P/E of 5.01. For a more detailed relative valuation and DCF analysis to assess Teva Pharmaceutical Industries Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

5.01

Current PE

11.93

Overvalued PE

7.12

Undervalued PE

2.90

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

5Y Average EV/EBITDA

7.39

Current EV/EBITDA

9.24

Overvalued EV/EBITDA

9.51

Undervalued EV/EBITDA

5.28

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

0.96

Current PS

2.25

Overvalued PS

1.40

Undervalued PS

0.52

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

si quiero con acciones de estados unidos

Intellectia · 30 candidates

Market Cap: >= 10.00BRegion: USPrice: $10.00 - $60.00Analyst Consensus: Strong BuyPe Ttm: 5 - 30List Exchange: XNYS, XNAS

Ticker

Name

Market Cap$

BAC

Bank of America Corp

384.66B

SLB

SLB NV

78.36B

Nu Holdings Ltd.

73.40B

Barrick Mining Corp

71.97B

MFC

Manulife Financial Corp

64.64B

BKR

Baker Hughes Co

58.68B

top 10 crypto gainers today

Intellectia · 512 candidates

Price Change Pct 24h: >= $0.00

Ticker

Name

Market Cap$

ZEX

Zeta

6.11M

MDT

Measurable Data Token

5.68M

AKE

AKEDO

9.28M

KIN

Kindred Labs

1.88M

UNITE

Unite

106.81K

CHILLGUY

Just a chill guy

11.99M

no which two coins under .01

Intellectia · 347 candidates

Turnover 24h: >= 0Price: $0.00 - $0.01Relative Vol: >= 0Dollar Volume 24h: >= 0

Ticker

Name

Market Cap$

PEPE

Pepe

1.65B

Gravity

56.10M

PUMP

Pump.fun

716.00M

BONK

Bonk

579.97M

PENGU

Pudgy Penguins

498.58M

SHIB

Shiba Inu

3.66B

What stoke should I buy ?

Intellectia · 60 candidates

Market Cap: >= 30.00BQuarter Revenue Yoy Growth: >= 10.0%Return On Equity: >= 15.0%Moving Average Relationship: PriceAboveMA200Monthly Average Dollar Volume: >= 1,500,000

Ticker

Name

Market Cap$

LITE

Lumentum Holdings Inc

42.87B

WDC

Western Digital Corp

96.32B

Micron Technology Inc

449.96B

FIX

Comfort Systems USA Inc

47.19B

Anglogold Ashanti PLC

53.60B

KGC

Kinross Gold Corp

40.90B

stocks to buy tomorrow

Intellectia · 358 candidates

Market Cap: >= 5.00BRegion: USList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20One Day Rise Prob: >= 55Monthly Average Dollar Volume: >= 2,000,000

Ticker

Name

Market Cap$

TER

Teradyne Inc

43.25B

DINO

HF Sinclair Corp

10.32B

ArcelorMittal SA

44.06B

AROC

Archrock Inc

5.35B

EXAS

Exact Sciences Corp

19.49B

AEP

American Electric Power Company Inc

64.75B

show me large cap stocks with key reversal

Intellectia · 44 candidates

Market Cap: >= 10.00BNew High Low: 52w_High, 52w_Low, 20_High, 20_LowCandlestick Pattern: UpperShadow, LowerShadow

Ticker

Name

Market Cap$

WMT

Walmart Inc

949.57B

CSCO

Cisco Systems Inc

309.45B

AZN

AstraZeneca PLC

287.64B

MRK

Merck & Co Inc

273.69B

TXN

Texas Instruments Inc

193.96B

MFG

Mizuho Financial Group Inc

106.59B

stocks currently in bullish trend

Intellectia · 39 candidates

Market Cap: >= 10.00BList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA200Quarter Price Change Pct: >= $50.00Monthly Average Dollar Volume: >= 2,000,000

Ticker

Name

Market Cap$

Micron Technology Inc

439.39B

NEM

Newmont Corporation

140.53B

CVNA

Carvana Co

104.69B

FCX

Freeport-McMoRan Inc

89.29B

Barrick Mining Corp

86.76B

WDC

Western Digital Corp

86.45B

give me your top pick

Intellectia · 10 candidates

Market Cap: >= 10.00BMarket Cap Category: mega, largeAnalyst Consensus: Strong BuyList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA20, PriceAboveMA200One Month Predict Return: >= 15.0%

Ticker

Name

Market Cap$

ROST

Ross Stores Inc

60.49B

NiSource Inc

20.77B

APG

APi Group Corp

18.28B

Whales Holding TEVA

Todd Asset Management LLC

More Investment House Ltd.

Clal Financial Management Ltd

Meitav Investment House Ltd

Migdal Mutual Funds Ltd.

Harel Insurance Investments & Financial Services Ltd

Trading Trends

People Also Watch

Frequently Asked Questions

What is Teva Pharmaceutical Industries Ltd (TEVA) stock price today?

The current price of TEVA is 32.02 USD — it has decreased -1.17

What is Teva Pharmaceutical Industries Ltd (TEVA)'s business?

What is the price predicton of TEVA Stock?

Wall Street analysts forecast TEVA stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TEVA is35.71 USD with a low forecast of 29.00 USD and a high forecast of 40.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Teva Pharmaceutical Industries Ltd (TEVA)'s revenue for the last quarter?

Teva Pharmaceutical Industries Ltd revenue for the last quarter amounts to 4.72B USD, increased 12.61

What is Teva Pharmaceutical Industries Ltd (TEVA)'s earnings per share (EPS) for the last quarter?

Teva Pharmaceutical Industries Ltd. EPS for the last quarter amounts to 0.41 USD, decreased -315.79

How many employees does Teva Pharmaceutical Industries Ltd (TEVA). have?

Teva Pharmaceutical Industries Ltd (TEVA) has 31173 emplpoyees as of April 21 2026.

What is Teva Pharmaceutical Industries Ltd (TEVA) market cap?

Today TEVA has the market capitalization of 37.28B USD.

TEVA Overview

TEVA Overview

Events Timeline

News

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Related Community Screener

Whales Holding TEVA

Trading Trends

People Also Watch

Frequently Asked Questions

What is Teva Pharmaceutical Industries Ltd (TEVA) stock price today?

What is Teva Pharmaceutical Industries Ltd (TEVA)'s business?

What is the price predicton of TEVA Stock?

What is Teva Pharmaceutical Industries Ltd (TEVA)'s revenue for the last quarter?

What is Teva Pharmaceutical Industries Ltd (TEVA)'s earnings per share (EPS) for the last quarter?

How many employees does Teva Pharmaceutical Industries Ltd (TEVA). have?

What is Teva Pharmaceutical Industries Ltd (TEVA) market cap?